Daily non-political popular news in brief.

Hepatitis B drug can compromise HIV treatment

Treating hepatitis B patients with the drug entecavir can cause those who are also infected with HIV to become resistant to two of the most important drugs in the anti-HIV arsenal. In findings published in the New England Journal of Medicine, researchers reported that a patient infected with both hepatitis B and HIV who was treated with entecavir developed a mutant strain of HIV that is resistant to the antiviral drugs lamivudine and emtricitabine.

Read more »

Keywords: hepatitis, drug, compromise, hiv, treatment, hepatiti

« Previous | Next »

Similar news on "Hepatitis B drug can compromise HIV treatment":

1. Widely used hepatitis B drug spurs HIV drug resistance
   02-28-2007 · EurekAlert!
   A Johns Hopkins study has proven false established medical practice that an antiretroviral drug widely used to treat hepatitis B liver infections was safe to use on its own in patients co-infected with HIV. Their findings demonstrate that treatment with entecavir leads to cross-resistance to other antiviral drugs used to treat the AIDS virus.
   Similar news · Read more »
   
2. Drug warning prompts treatment changes for those infected with hepatitis B and HIV
   06-20-2007 · EurekAlert!
   Cross-resistance alarms raised earlier this year by Johns Hopkins researchers about a widely used antiviral therapy for hepatitis B liver infections have prompted swift treatment revisions by the drug's maker and governmental agencies.
   Similar news · Read more »
   
3. European approval of HIV drug darunavir will provide a potent new option with Fuzeon
   02-16-2007 · EurekAlert!
   Today's approval of the new protease inhibitor (PI) darunavir (boosted with ritonivir) provides physicians with the opportunity to build a potent new treatment combination with the fusion inhibitor, Fuzeon.
   Similar news · Read more »
   
4. HIV-positive people getting heavier
   10-27-2007 · Science News Online
   With drug treatment, HIV-infected people no longer suffer from wasting but are about as overweight or obese as the U.S. population as a whole.
   Similar news · Read more »
   
5. Extensively drug-resistant tuberculosis is emerging threat
   10-27-2006 · EurekAlert!
   Strains of tuberculosis (TB) that are resistant to both first-line and second-line drugs could threaten the success of not only tuberculosis programs, but also HIV treatment programs worldwide, according to an article published online this week in the Lancet.
   Similar news · Read more »
   
6. Resistance to anti-HIV drugs in Uganda developed due to drug supply problems
   04-22-2007 · EurekAlert!
   Some HIV-infected patients in Uganda who self paid for their antiretroviral medications experienced interruptions in drug supply due to either financial demands or supply logistical disruptions. These treatment interruptions led to the development of resistance to antiretroviral medications in patients.
   Similar news · Read more »
   
7. Hepatitis B patients' understanding of infection and treatment deficient
   05-24-2007 · EurekAlert!
   Many patients with chronic hepatitis B are deficient in their understanding of the lifelong disease and often do not comply with the drug regimens necessary to control it, according to a new UCLA survey that suggests improved patient involvement in disease management decisions could be the key to fixing this problem.
   Similar news · Read more »
   
8. Injection drug use and HIV and HCV infections among Ontario prison inmates
   07-30-2007 · EurekAlert!
   In this issue of CMAJ, two research groups report on the prevalence of HIV and hepatitis C virus infections in different inmate populations: people in provincial prisons in Quebec, and adult and young offenders admitted to remand facilities (jails, detention centres and youth centers) in Ontario. The Ontario study is highlighted below; the Quebec study appears in a separate release posted on EurekAlert today.
   Similar news · Read more »
   
9. New drug reduces abdominal fat accumulation and improves lipids in HIV-infected patients
   12-05-2007 · EurekAlert!
   Treatment with an investigational drug that induces the release of growth hormone significantly improved the symptoms of HIV lipodystrophy, a condition involving the redistribution of fat and other metabolic changes in patients receiving combination drug therapy for HIV infection.
   Similar news · Read more »
   
10. Injection drug use the most important risk factor for HIV and HCV infections among Quebec prisoners
    07-30-2007 · EurekAlert!
    In this issue of CMAJ, 2 research groups report on the prevalence of HIV and hepatitis C virus infections in different inmate populations: people in provincial prisons in Quebec, and adult and young offenders admitted to remand facilities (jails, detention centers and youth centers) in Ontario. The Ontario study is highlighted below; the Quebec study appears in a separate release posted on EurekAlert! today.
    Similar news · Read more »